View in EDS HTML Full Text PDF Full Text

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Saved in:
Bibliographic Details
Title: Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
Authors: Seppälä TT; 1Department of Surgery, Helsinki University Central Hospital, P.O. Box 340, 00029 HUS Helsinki, Finland.; 2University of Helsinki, Helsinki, Finland., Ahadova A; 3Heidelberg University Hospital and DKFZ, Heidelberg, Germany., Dominguez-Valentin M; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 5Department of Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Macrae F; 6The Royal Melbourne Hospital, Melbourne, Australia.; 7University of Melbourne, Melbourne, Australia., Evans DG; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Therkildsen C; The Danish HNPCC Register, Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark., Sampson J; 10Medical Genetics, Cardiff University, Cardiff, UK., Scott R; University of Newcastle and the Hunter Medical Research Institute, Callaghan, Australia., Burn J; 12University of Newcastle, Newcastle upon Tyne, UK., Möslein G; 13University Witten-Herdecke, Wuppertal, Germany., Bernstein I; 14Dept. of Surgical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark., Holinski-Feder E; 15Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 16MGZ- Medical Genetics Center, Munich, Germany., Pylvänäinen K; 17Central Finland Central Hospital, Education and Research, Jyväskylä, Finland., Renkonen-Sinisalo L; 1Department of Surgery, Helsinki University Central Hospital, P.O. Box 340, 00029 HUS Helsinki, Finland., Lepistö A; 1Department of Surgery, Helsinki University Central Hospital, P.O. Box 340, 00029 HUS Helsinki, Finland., Lautrup CK; 18Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark., Lindblom A; 19Karolinska Institutet, Stockholm, Sweden., Plazzer JP; 6The Royal Melbourne Hospital, Melbourne, Australia., Winship I; 6The Royal Melbourne Hospital, Melbourne, Australia.; 7University of Melbourne, Melbourne, Australia., Tjandra D; 6The Royal Melbourne Hospital, Melbourne, Australia., Katz LH; 20Hadassah Medical Center, Jerusalem, and Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel., Aretz S; 21Institute of Human Genetics, University of Bonn, Bonn, Germany., Hüneburg R; 22Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; 23Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Holzapfel S; 22Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; 23Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Heinimann K; 24Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Valle AD; Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay., Neffa F; Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay., Gluck N; Tel-Aviv Soursky Medical Center, Tel-Aviv, Israel., de Vos Tot Nederveen Cappel WH; 27Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, The Netherlands., Vasen H; 28Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., Morak M; 15Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 16MGZ- Medical Genetics Center, Munich, Germany., Steinke-Lange V; 15Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 16MGZ- Medical Genetics Center, Munich, Germany., Engel C; 29Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Rahner N; 30Medical School, Institute of Human Genetics, Heinrich-Heine-University, Düsseldorf, Germany., Schmiegel W; 31Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany., Vangala D; 31Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany., Thomas H; 32St Mark's Hospital, Department of Surgery and Cancer, Imperial College London, London, UK., Green K; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Lalloo F; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Crosbie EJ; 33University of Manchester and St Mary's Hospital, Manchester, UK., Hill J; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Capella G; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Blanco I; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Ten Broeke S; 36University Medical Center Groningen, Groningen, the Netherlands., Nielsen M; 37Leids Universitair Medisch Centrum, Leiden, Netherlands., Ljungmann K; 38Department of Surgical Gastroenterology, Aarhus University Hospital, Aarhus, Denmark., Nakken S; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway., Lindor N; 39Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ USA., Frayling I; 10Medical Genetics, Cardiff University, Cardiff, UK., Hovig E; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 40Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Sunde L; 41Department of Medical Genetics, Aarhus University Hospital, Aarhus, Denmark., Kloor M; 3Heidelberg University Hospital and DKFZ, Heidelberg, Germany., Mecklin JP; 42Department of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.; 43Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland., Kalager M; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 44University of Oslo, Oslo, Norway.; 45Harvard School of Public Health, Boston, MA USA., Møller P; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 13University Witten-Herdecke, Wuppertal, Germany.; 5Department of Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Source: Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2019 Feb 28; Vol. 17, pp. 8. Date of Electronic Publication: 2019 Feb 28 (Print Publication: 2019).
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: Poland NLM ID: 101231179 Publication Model: eCollection Cited Medium: Print ISSN: 1731-2302 (Print) Linking ISSN: 17312302 NLM ISO Abbreviation: Hered Cancer Clin Pract Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1731-2302
DOI:10.1186/s13053-019-0106-8